Benefits
Helps blunt post-meal blood sugar spikes
Single doses of standardized Salacia extracts taken with carbohydrate-rich meals have been shown to reduce post-meal rises in blood glucose and insulin in healthy adults and patients with type 2 diabetes, supporting smoother glycemic responses after large or starchy meals.
Supports healthy fasting glucose
Six-week and longer trials of standardized Salacia reticulata root and bark extracts in adults with prediabetes and mild hyperlipidemia have shown reductions in fasting blood sugar versus placebo, supporting healthy fasting glucose maintenance alongside lifestyle measures.
Helps support healthy lipid balance
In adults with prediabetes and mild to moderate hyperlipidemia, Salacia reticulata extracts have been associated with reductions in LDL cholesterol versus placebo over 6 weeks, supporting a healthier overall lipid pattern as part of broader metabolic-support strategies.
Provides a complement to GLP-1-style dietary strategies
By slowing carbohydrate digestion in the upper small intestine, Salacia extracts can shift undigested carbohydrate distally and modulate gut hormone responses, complementing dietary approaches aimed at supporting incretin signaling and satiety.
Traditional Ayurvedic metabolic support
Kothala Himbutu has a long Ayurvedic and Sri Lankan history of use for sweet urine disease and metabolic complaints, supporting its continued framing as a traditional botanical for healthy weight and blood sugar maintenance within evidence-based supplement formulations.
Mechanism of action
Intestinal alpha-glucosidase inhibition
Salacinol, kotalanol, and their de-O-sulfonated forms inhibit alpha-glucosidase enzymes such as maltase, sucrase, and isomaltase at the intestinal brush border, slowing the breakdown of complex carbohydrates into absorbable monosaccharides and blunting postprandial glucose rises.
Modulation of incretin and gut microbiota
By delivering more carbohydrate to the distal small intestine and colon, Salacia extracts increase breath hydrogen and may modulate L-cell incretin secretion and gut microbiota composition, supporting incretin-related metabolic effects and changes in microbial fermentation.
Mangiferin and polyphenol contribution
Mangiferin and related polyphenols in Salacia species contribute antioxidant and PPAR-related signaling that may complement alpha-glucosidase inhibition, supporting effects on lipid handling and insulin sensitivity observed in longer-term clinical studies.
Clinical trials
Double-masked, randomized crossover trial of 500, 700, or 1,000 mg of Salacia oblonga extract with a standardized high-carbohydrate meal compared with no extract (Heacock et al., Journal of the American Dietetic Association).
Healthy adults in a crossover design.
The highest dose of Salacia extract reduced the postprandial plasma glucose incremental area under the curve by about 23 percent and serum insulin AUC by about 29 percent, with concurrent rises in breath hydrogen consistent with carbohydrate-malabsorption mechanism. Supports acute postprandial benefits of Salacia alpha-glucosidase inhibition.
Randomized, single-center, double-blind crossover study of an herbal preparation containing Salacia reticulata in type 2 diabetes over 3 months per phase (Jayawardena et al., Journal of Ethnopharmacology).
Adult patients with type 2 diabetes.
Salacia reticulata-containing herbal tea improved fasting and postprandial glycemia compared with placebo over 3 months, with reductions in HbA1c reported in the active arm. Provides among the earliest longer-term human evidence for Salacia reticulata as an adjunct in type 2 diabetes management.
Randomized, double-blind crossover trial of 240 mg or 480 mg of Salacia oblonga extract added to a high-carbohydrate liquid meal in patients with type 2 diabetes (Williams et al., American Journal of Clinical Nutrition).
66 patients with type 2 diabetes.
Both doses of Salacia oblonga significantly lowered the postprandial positive glucose area under the curve and the adjusted peak glucose response, with effects of about 14–22 percent reduction in glucose AUC across the two doses. Supports Salacia species as adjuncts for postprandial glucose control in type 2 diabetes.